Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepato-Renal Syndrome”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Not applicableStudy completedNCT04273750
What this trial is testing

RAI & HRS: Relationship Between Relative Adrenal Insufficiency and Failure of Treatment in Hepatorenal Syndrome

Who this might be right for
Liver CirrhosisAcute Kidney InjuryHepato-Renal Syndrome
University Hospital Plymouth NHS Trust 26
Post-approval studies (Phase 4)Ended earlyNCT02034279
What this trial is testing

The INFECIR-2 Albumin Prevention Study

Who this might be right for
Advanced Chronic Liver DiseaseUrinary InfectionPneumonia+2 more
EASL - CLIF Consortium 136
Post-approval studies (Phase 4)Study completedNCT03455322
What this trial is testing

Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.

Who this might be right for
Renal Impairment in Hepatorenal Syndrome
National Hepatology & Tropical Medicine Research Institute 60
Testing effectiveness (Phase 2)WithdrawnNCT01587222
What this trial is testing

Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure

Who this might be right for
FibrosisRenal FailureHepatorenal Syndrome
Anna Cruceta
Early research (Phase 1)Ended earlyNCT01906307
What this trial is testing

LJPC-501 in Patients With Hepatorenal Syndrome

Who this might be right for
Hepatorenal Syndrome Type I and Type II
La Jolla Pharmaceutical Company 6
Not applicableStudy completedNCT04522297
What this trial is testing

Nor-epinephrine Versus Midodrine/Octreotide in Patients With Hepatorenal Syndrome

Who this might be right for
Hepato-Renal Syndrome
National Hepatology & Tropical Medicine Research Institute 91
Large-scale testing (Phase 3)Study completedNCT04460560
What this trial is testing

Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)

Who this might be right for
Hepatorenal Syndrome
University of Pennsylvania 50
Not applicableUnknownNCT05434286
What this trial is testing

Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney Injury

Who this might be right for
Hepatorenal SyndromeCirrhosis, LiverAcute-On-Chronic Liver Failure+2 more
Post Graduate Institute of Medical Education and Research, Chandigarh 75
Not applicableTemporarily pausedNCT04898010
What this trial is testing

The Selective Cytopheretic Device (SCD) for Acute Kidney Injury (AKI) and Hepatorenal Syndrome (HRS) Type I

Who this might be right for
Acute Kidney InjuryHepatorenal Syndrome
Lenar Yessayan 10
Not applicableEnded earlyNCT02123576
What this trial is testing

Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline

Who this might be right for
Hepatorenal Syndrome
Patrick Northup, MD 12
Large-scale testing (Phase 3)UnknownNCT00742690
What this trial is testing

Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome

Who this might be right for
CirrhosisType 1 Hepatorenal Syndrome
University of Padova 70
Large-scale testing (Phase 3)Ended earlyNCT06000748
What this trial is testing

NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients

Who this might be right for
Acute Kidney InjuryCirrhosisPortal Hypertension+3 more
University of California, San Francisco 6
Large-scale testing (Phase 3)Study completedNCT02770716
What this trial is testing

Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1

Who this might be right for
Hepatorenal Syndrome
Mallinckrodt 300
Large-scale testing (Phase 3)Ended earlyNCT00742339
What this trial is testing

Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome

Who this might be right for
CirrhosisHepatorenal Syndrome
University of Padova 49
Not applicableLooking for participantsNCT02434445
What this trial is testing

Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients

Who this might be right for
Hepatorenal Syndrome
The University of Hong Kong 100
Not applicableUnknownNCT04986137
What this trial is testing

Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis

Who this might be right for
Acute Kidney Injury
Sohag University 100
Large-scale testing (Phase 3)Study completedNCT01143246
What this trial is testing

A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin

Who this might be right for
Hepatorenal Syndrome
Mallinckrodt 196
Not applicableUnknownNCT03530761
What this trial is testing

Korean Cohort Study of AKI & HRS in Cirrhosis

Who this might be right for
Liver CirrhosisAcute Kidney InjuryHepatorenal Syndrome
Soonchunhyang University Hospital 245
Testing effectiveness (Phase 2)WithdrawnNCT04048707
What this trial is testing

Angiotensin 2 for Hepatorenal Syndrome

Who this might be right for
Hepatorenal SyndromeCirrhosisKidney Failure, Acute
University of California, Los Angeles
Not applicableUnknownNCT02906345
What this trial is testing

TPE in Septic Patients and Influence on Organ Failure

Who this might be right for
Multiple Organ Failure
University of Rostock 30
Load More Results